CLRB News and Press, Cellectar Biosciences Inc. From 02/19/21

Interest in Cellectar Biosciences (CLRB) from private equity firms this week jumped this week as evidenced by several SEC Form 13G and Form 13G/A amended filings.This week, Consonance Capital Management and Sio Capital Management both filed Form 13G.Consonance's filing lists 4,...

FLORHAM PARK, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that James Caruso, presid...

Analysts Say These Are Penny Stocks To Buy; Do You Agree? We talk a lot about penny stocks for obvious reasons. But do you know how to find the right stocks to buy? I’m sure that if you’re like most in the stock market today, you’re searching for volatility. We ...

The EMA has adopted a positive opinion for Cellectar Biosciences' (CLRB) CLR 131 orphan designation for the treatment of Waldenstrom’s Macroglobulinemia ((WM)). Cellectar has initiated a pivotal trial evaluating CLR 131 in WM patients that have failed or had a suboptimal response to a ...

FLORHAM PARK, N.J., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the European Medicin...

Cellectar Biosciences ([[CLRB]] +4.3%) has initiated a pivotal trial in the U.S., for CLR 131 in Waldenstrom’s macroglobulinemia ((WM)), a rare cancer of the bone marrow and lymphatic tissues.The pivotal trial is designed as a global, non-comparator, single arm, expansion cohort of the...

FLORHAM PARK, N.J., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced the initiation of a pivot...

Insiders Made These Their Top Penny Stocks To Buy Before The New Year Whether we’re talking about penny stocks or blue-chip stocks, insider transactions are always something of interest for traders. Playing more to the psychology of day trading or investing, when insiders...

FLORHAM PARK, N.J., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the closing of its previously a...

Biotech Penny Stocks To Watch With Recent Updates It’s funny to think that 2020 is almost over yet penny stocks remain a major focus for traders right now. One of the main reasons for this has been the unrelenting focus on volatility. Believe it or not, I think 2020 was p...